|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/12/2024 |
$3.10 |
$3.24 |
$3.00 |
$3.05 |
22.80K | 04/15/2024 |
$3.11 |
$3.42 |
$2.94 |
$2.94 |
16.30K | 04/16/2024 |
$2.88 |
$3.15 |
$2.71 |
$3.05 |
15.90K | 04/17/2024 |
$3.19 |
$3.47 |
$2.87 |
$3.24 |
745.20K | 04/18/2024 |
$5.41 |
$7.67 |
$3.56 |
$4.20 |
83.23M |
|
Bio-Path Holdings is a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company utilizing a technology that achieves systemic delivery for target specific protein inhibition for any gene product that is over-expressed in disease. Co.'s primary drug candidate, prexigebersen, which targets growth factor receptor-bound protein 2, initially started the efficacy portion of a Phase 2 clinical trial for untreated acute myeloid leukemia patients. Co.'s second drug candidate, Liposomal Bcl-2, targets the protein Bcl-2, which is responsible for driving cell survival in up to 60% of all cancers. Co.'s third drug candidate, Liposomal STAT3, targets the STAT3 protein. | |
|
Bio-Path Holdings (BPTH) has the following price history information. Looking back at BPTH historical stock prices for the last five trading days, on April 12, 2024, BPTH opened at $3.10, traded as high as $3.24 and as low as $3.00, and closed at $3.05. Trading volume was a total of 22.80K shares. On April 15, 2024, BPTH opened at $3.11, traded as high as $3.42 and as low as $2.94, and closed at $2.94. Trading volume was a total of 16.30K shares. On April 16, 2024, BPTH opened at $2.88, traded as high as $3.15 and as low as $2.71, and closed at $3.05. Trading volume was a total of 15.90K shares. On April 17, 2024, BPTH opened at $3.19, traded as high as $3.47 and as low as $2.87, and closed at $3.24. Trading volume was a total of 745.20K shares. On April 18, 2024, BPTH opened at $5.41, traded as high as $7.67 and as low as $3.56, and closed at $4.20. Trading volume was a total of 83.23M shares.
BPTH Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Bio-Path Holdings shares, starting with a $10,000 purchase of BPTH, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/22/2014 |
|
End date: |
04/18/2024 |
|
Start price/share: |
$10,560.00 |
|
End price/share: |
$4.20 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.96% |
|
Average Annual Total Return: |
-54.31% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$3.97 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
04/12/2024 | $3.05 | 04/15/2024 | $2.94 | 04/16/2024 | $3.05 | 04/17/2024 | $3.24 | 04/18/2024 | $4.20 |
|
|